Potential of circulating tumor cells as blood-based biomarkers in cancer liquid biopsy

被引：17
作者：
Schlange, Thomas [1 ]
Pantel, Klaus [2 ]
机构：
[1] Bayer Pharma AG, Global Biomarker Res, D-42096 Wuppertal, Germany
[2] Univ Med Ctr Hamburg Eppendorf, Dept Tumour Biol, D-20246 Hamburg, Germany
来源：
PHARMACOGENOMICS | 2016年 / 17卷 / 03期
关键词：
blood-based biomarkers; circulating tumor cells; liquid biopsy; personalized medicine; tumor heterogeneity; METASTATIC BREAST-CANCER; RESISTANT PROSTATE-CANCER; LUNG-CANCER; COLORECTAL-CANCER; PROGRESSION-FREE; HER2; EXPRESSION; STEM-CELLS; SURVIVAL; THERAPY; DNA;
D O I：
10.2217/pgs.15.163
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：183 / 186
页数：4
相关论文
共 42 条
  • [1] Efficacy of Lapatinib in Therapy-Resistant HER2-Positive Circulating Tumor Cells in Metastatic Breast Cancer
    Agelaki, Sofia
    Kalykaki, Antonia
    Markomanolaki, Harris
    Papadaki, Maria A.
    Kallergi, Galatea
    Hatzidaki, Dora
    Kalbakis, Kostas
    Mavroudis, Dimitrios
    Georgoulias, Vassilis
    [J]. PLOS ONE, 2015, 10 (06):
  • [2] Alix-Panabieres C, NAT REV CANC, V14, P623
  • [3] Circulating Tumor Cells: Liquid Biopsy of Cancer
    Alix-Panabieres, Catherine
    Pantel, Klaus
    [J]. CLINICAL CHEMISTRY, 2013, 59 (01) : 110 - 118
  • [4] [Anonymous], 2013, RES TRENDS CLIN UTIL, V134
  • [5] AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
    Antonarakis, Emmanuel S.
    Lu, Changxue
    Wang, Hao
    Luber, Brandon
    Nakazawa, Mary
    Roeser, Jeffrey C.
    Chen, Yan
    Mohammad, Tabrez A.
    Chen, Yidong
    Fedor, Helen L.
    Lotan, Tamara L.
    Zheng, Qizhi
    De Marzo, Angelo M.
    Isaacs, John T.
    Isaacs, William B.
    Nadal, Rosa
    Paller, Channing J.
    Denmeade, Samuel R.
    Carducci, Michael A.
    Eisenberger, Mario A.
    Luo, Jun
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (11) : 1028 - 1038
  • [6] Ashworth T R, 1869, MED J AUSTRALIA, V1, P146
  • [7] Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data
    Bidard, Francois-Clement
    Peeters, Dieter J.
    Fehm, Tanja
    Nole, Franco
    Gisbert-Criado, Rafael
    Mavroudis, Dimitrios
    Grisanti, Salvatore
    Generali, Daniele
    Garcia-Saenz, Jose A.
    Stebbing, Justin
    Caldas, Carlos
    Gazzaniga, Paola
    Manso, Luis
    Zamarchi, Rita
    Fernandez de Lascoiti, Angela
    De Mattos-Arruda, Leticia
    Ignatiadis, Michail
    Lebofsky, Ronald
    van Laere, Steven J.
    Meier-Stiegen, Franziska
    Sandri, Maria-Teresa
    Vidal-Martinez, Jose
    Politaki, Eleni
    Consoli, Francesca
    Bottini, Alberto
    Diaz-Rubio, Eduardo
    Krell, Jonathan
    Dawson, Sarah-Jane
    Raimondi, Cristina
    Rutten, Annemie
    Janni, Wolfgang
    Munzone, Elisabetta
    Caranana, Vicente
    Agelaki, Sofi A.
    Almici, Camillo
    Dirix, Luc
    Solomayer, Erich-Franz
    Zorzino, Laura
    Johannes, Helene
    Reis-Filho, Jorge S.
    Pantel, Klaus
    Pierga, Jean-Yves
    Michiels, Stefan
    [J]. LANCET ONCOLOGY, 2014, 15 (04) : 406 - 414
  • [8] To differentiate or not - routes towards metastasis
    Brabletz, Thomas
    [J]. NATURE REVIEWS CANCER, 2012, 12 (06) : 425 - 436
  • [9] Establishment and Characterization of a Cell Line from Human Circulating Colon Cancer Cells
    Cayrefourcq, Laure
    Mazard, Thibault
    Joosse, Simon
    Solassol, Jerome
    Ramos, Jeanne
    Assenat, Eric
    Schumacher, Udo
    Costes, Valerie
    Maudelonde, Thierry
    Pantel, Klaus
    Alix-Panabieres, Catherine
    [J]. CANCER RESEARCH, 2015, 75 (05) : 892 - 901
  • [10] Non-small-cell lung cancers: a heterogeneous set of diseases
    Chen, Zhao
    Fillmore, Christine M.
    Hammerman, Peter S.
    Kim, Carla F.
    Wong, Kwok-Kin
    [J]. NATURE REVIEWS CANCER, 2014, 14 (08) : 535 - 546
12345